APA (7th ed.) Citation

Jr, G. L., B, J., Z, E., A, Y., R, K., B, K., & J, G. (2024). Estimating the Allocation of the Economic Value Generated by Utilization of All-Oral Direct-Acting Antivirals for Hepatitis C in the United States, 2015 to 2019. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 27(8), 1021. https://doi.org/10.1016/j.jval.2024.04.011

Chicago Style (17th ed.) Citation

Jr, Garrison LP, Jiao B, Elsisi Z, Yehoshua A, Koruth R, Kreter B, and Grueger J. "Estimating the Allocation of the Economic Value Generated by Utilization of All-Oral Direct-Acting Antivirals for Hepatitis C in the United States, 2015 to 2019." Value in Health : The Journal of the International Society for Pharmacoeconomics and Outcomes Research 27, no. 8 (2024): 1021. https://doi.org/10.1016/j.jval.2024.04.011.

MLA (9th ed.) Citation

Jr, Garrison LP, et al. "Estimating the Allocation of the Economic Value Generated by Utilization of All-Oral Direct-Acting Antivirals for Hepatitis C in the United States, 2015 to 2019." Value in Health : The Journal of the International Society for Pharmacoeconomics and Outcomes Research, vol. 27, no. 8, 2024, p. 1021, https://doi.org/10.1016/j.jval.2024.04.011.